eISSN: 2709-2577
pISSN: 2709-2569

The publication of results of all randomized control trials will only be considered if the ICMJE recommendations are followed. A registration number will have to be provided with the manuscript and should be noted after the end of the abstract.

The ICMJE defines a clinical trial as “any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioral treatments, educational programs, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.”

The ICMJE endorses the following:

1. Any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/network/primary/en/index.html)

2. ClinicalTrials.gov

The Drug Regulatory Authority of Pakistan (DRAP) also provides approval and trial numbers for clinical trials involving drugs or appliances (http://www.dra.gov.pk/) A number of other clinical trial registries and their details can be found on the internet. Reference: http://www.icmje.org/icmje-recommendations.pdf